US CLOSED

SPX7,541.40-0.51%DJI51,983.98+0.41%COMP25,164.36-1.07%RUT2,805.88-0.21%VIX21.15+8.91%US10Y4.89-0.71%SPY752.10-0.48%QQQ681.09-1.36%IWM279.14-0.07%AAPL338.32-1.83%MSFT507.12-2.83%NVDA202.06-1.26%AMZN245.63+2.20%META606.73-1.34%GOOGL278.99-0.30%TSLA403.82+1.00%JPM340.58+1.05%GS898.72+0.47%SPX7,541.40-0.51%DJI51,983.98+0.41%COMP25,164.36-1.07%RUT2,805.88-0.21%VIX21.15+8.91%US10Y4.89-0.71%SPY752.10-0.48%QQQ681.09-1.36%IWM279.14-0.07%AAPL338.32-1.83%MSFT507.12-2.83%NVDA202.06-1.26%AMZN245.63+2.20%META606.73-1.34%GOOGL278.99-0.30%TSLA403.82+1.00%JPM340.58+1.05%GS898.72+0.47%

US cash 09:30-16:00 ET

Join

Software Calculators Markets News Course About Contact FAQ

News

healthcare

Sep 26, 2026
Hims & Hers Is Growing Fast. Its Next Test Is the Quality of That Growth
Revenue and subscribers rose in Q2 2026. Thinner margins, negative cash flow, a GLP-1 transition, and a pending lawsuit complicate the picture.

healthcare

Hims & Hers Is Growing Fast. Its Next Test Is the Quality of That Growth